Treatment of Post-Transplanted, Relapsed Patients with Hematological Malignancies by Infusion of HLA-Matched, Allogeneic-Dendritic Cells (DCs) Pulsed with Irradiated Tumor Cells and Primed T Cells

References

• Kumar L. Donor leukocyte infusion for relapse in chronic myelogenous leukaemia. Lancet 1994; 344: 1101–1104
   PubMed Web of Science ®Google Scholar
• Porter D. L., Roth M. S., McGarigle C., Ferrara J. L., Antin J H. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukaemia. New England Journal of Medicine 1994; 330: 100–106
   PubMed Web of Science ®Google Scholar
• Banchereau J., Steinman R M. Dendritic cells and the control of immunity. Nature 1998; 392: 245–252
   PubMed Web of Science ®Google Scholar
• Hart D. N.I. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997; 90: 3245–3287
   PubMed Web of Science ®Google Scholar
• Hsu F. F., Benike C., Fagnoni F., Liles T. M., Czerwinski D., Taidi B., Engleman E. G., Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nature Medicne 1996; 2: 52–58
   PubMed Web of Science ®Google Scholar
• Hsu F. J., Caspar C. B., Czerwinski D., Kwak L. W., Lues T. M., Syrengelas A., Taidi-Laskowski B., Levy R. Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma-long-term results of a clinical trial. Blood 1997; 89: 3129–3135
   PubMed Web of Science ®Google Scholar
• Nelson E. L., Li X., Hsu F. J., Kwak L. W., Levy R., Clayberger C., Krensky A M. Tumor-specific, cytotoxic T-lymphocyte response after idiotype vaccination for B-cell, non-Hodgkin's lymphoma. Blood 1996; 88: 580–589
   PubMed Web of Science ®Google Scholar
• Nestle F., Alijagic S., Gilliet M., Sun Y., Grabbe S., Dummer R., Burg G., Schadendorf D. Vaccination of melanoma patients with peptide-or rumour lysate-pulsed dendritic cells. Nature Medicine 1998; 4: 328–332
   PubMed Web of Science ®Google Scholar
• Fujü S. I., Fujimoto K., Osato M., Matsui K., Takatsuki K., Kawakita M. Induction of antitumor cytotoxic activity using CD34+ cord blood cell-derived and irradiated tumour cell-primed dendritic cells. International Journal of Hematology 1998; 68: 169–182
   PubMed Web of Science ®Google Scholar
• Fujü S. I., Fujimoto K., Shimizu K., Ezaki T., Kawano F., Takatsuki K., Kawakita M., Matsuno K. Presentation of tumour antigens by phagocytic dendritic cell clusters generated from CD34+ hematopoietic progenitor cells: induction of autologous cytotoxic T lymphocytes against leukemic cells in acute myelogenous leukemia patients. Cancer Research 1999; 59: 2150–2158
   PubMed Web of Science ®Google Scholar
• Fujii S. I., Hamada H., Fujimoto K., Shimomura T., Kawakita M. Activated dendritic cells from bone marrow cells of mice receiving cytokine-expressing tumor cells are associated with the enhanced survival of mice. Blood 1999; 12: 4328–4335
   Google Scholar
• Weidmann E., Brieger J., Jahn B., Hoelzer D., Bergmann L., Mitrou P S. Lactate dehydrogenase-release assay: A reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukaemia. Annual Hematology 1995; 70: 153–158
   PubMed Web of Science ®Google Scholar
• Picker L. J., Singh M. K., Zdraveski Z., Treer J. R., Waldrop S. L., Bergstresser P. R., Maino V C. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood 1995; 86: 1408–1419
   PubMed Web of Science ®Google Scholar
• Fujü S. I., Shimizu K., Fujimoto K., Kiyokawa T., Shimomura T., Kinoshita M., Kawano F. Analysis of a chronic myelogenous leukemia patient vaccinated with leukemic dendritic cells following autologous peripheral blood stem cell transplantation. Japanese Journal of Cancer Research 1999; 90: 1117–1129
   PubMedGoogle Scholar
• Siena S., Nicola M. D., Bregni M., Mortarini R., Anichini A., Lombardi L., Ravagnani F., Parmiani G., Gianni A M. Massive ex vivo generation of functional dendritic cells from CD34+ blood progenitors for anticancer therapy. Experimental Hematology 1995; 23: 1463–1471
   PubMed Web of Science ®Google Scholar
• Herbst B., Kohler G., Mackensen A., Veelken H., Mertelsmann R., Lindemann A. CD34+ peripheral blood progenitor cell and monocyte derived dendritic cells: a comparative analysis. British Journal of Haematology 1997; 99: 490–499
   PubMed Web of Science ®Google Scholar
• Tarte K., Lu Z. Y., Fiol G., Legouffe E., Rossi J. F., Klein B. Generation of virtually pure and potentially proliferating dendritic cells from non-CD34 apheresis cells from patients with multiple myeloma. Blood 1997; 90: 3482–95
   PubMed Web of Science ®Google Scholar
• Choi D., Perrin M., Hoffmann S., Chang A. E., Ratanatharathorn V., Uberti J., McDonagh K. T., Mule J J. Dendritic cell-baed vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilised peripheral blood can serve as a source of potent dendritic cells. Clinical Cancer Research 1998; 4: 2709–16
   PubMed Web of Science ®Google Scholar
• Glass D., Uharek L., Zeis M., Dreger P., Loftier H., Steinmann J., Schmitz N. Allogeneic peripheral blood progenitor cell transplantation in murine model: evidence for an unproved graft-versus-leukaemia effect. Blood 1997; 90: 1694–1700
   PubMed Web of Science ®Google Scholar
• Sullivan K. M., Storb R., Buckner C. D., Fefer A., Fisher L., Weiden P. L., Witherspoon R. P., Appelbaum F. R., Bauaji M., Hansen J., Martin P., Sanders J. E., Singer J., Thomas E D. Graft-versus-host-disease as adoptive immunotherapy üi patients with advanced hematologic neoplasms. New England Journal of Medicine 1989; 32: 929–834
   Google Scholar
• Shlomchik W. D., Emerson G. The immunobiology of T cell therapies for leukemias. Acta Haematologica 1996; 96: 189–213
   PubMed Web of Science ®Google Scholar
• Young J. W., Papadopoulous E. B., Cunningham I., Castro-Malaspine H., Flomemberg N., Carabasi M. H., Gulati S. C., Bronchstein J. A., Heller G., Black P., Collinse N. H., Shank B., Kernan N. A., O'Reilly R J. T cell-depleted allogeneic bone marrow transplantation in adults with acute nonlymphocytic leukemia in first remission. Blood 1992; 79: 3380–3387
   PubMed Web of Science ®Google Scholar
• Papadopoulous E. B., Cabarasi M., Castro-Malaspina H., Childs B. H., Mackinnon S., Boulad F., Gillio A. P., Kernan N. A., Small T. N., Szabolcs P., Taylor J., Yahalom J., Collins N. H., Bleau S. A., Black P. M., Heller G., O'Reilly R. J., Young J W. T cell-depleted allogeneic bone marrow transplantation as post-remission therapy for acute myelogeneous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood 1998; 91: 1083–1090
   PubMedGoogle Scholar
• Marmont A. M., Horowitz M. M., Gale R. P., Sobocinski K., Ash R. C., van Bekkum D. W., Champlin R. E., Dicke K. A., Goldman J. M., Good R. A., Herzig R. H., Hong R., Masaoka T., Rimm A. A., Ringden O., Speck. B., Werner R. S., Bortin M M. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120–2130
   PubMed Web of Science ®Google Scholar
• Kolb H. J., Schattenberg A., Goldman J. M., Hertenstein B., Jacobsen N., Arvese W., Ljugman P., Ferrant A., Verdonck L., Niederweiser D., van Rhee F., Mittermueller J., de Witte T., Holler E., Ansari H., for the European Group for Blood and Marrow Transplanatation Working Party Chronic Leukemia. Graft-versus-leukemia effect of donor lymphocyte transfusion in marrow grafted patients. Blood 1995; 86: 2041–2059
   PubMed Web of Science ®Google Scholar
• Alessandrino E. P., Bernasconi P., Caldera D., Colombo A., Malcovati L., Martinellli G., Bonfichi M., Pagnucco G., Salvaneschi L., Bernasconi C. Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation. Bone Marrow Transplantation 1999; 23: 607–612
   PubMed Web of Science ®Google Scholar
• Childs R., Clave E., Contentin N., Jayasekera D., Hensel N., Leitman S., Read E. J., Carter C., Bahceci E., Young N. S., Barrett A J. Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood 1999; 94: 3234–3241
   PubMed Web of Science ®Google Scholar